ici 169369 has been researched along with Decerebrate Posturing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pires, JG; Ramage, AG | 1 |
| Blackburn, TP; Cox, B; Pearce, RJ; Thornber, CW | 1 |
2 other study(ies) available for ici 169369 and Decerebrate Posturing
| Article | Year |
|---|---|
Evidence suggesting that the 5-HT2 antagonist ICI 169,369 activates vagal afferents and in addition has a central hypotensive action in anaesthetized rats.
Topics: Afferent Pathways; Anesthesia; Animals; Blood Pressure; Brain; Decerebrate State; Heart Rate; Male; Quinolines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Vagus Nerve | 1990 |
Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonist.
Topics: Amphetamine; Animals; Behavior, Animal; Blood Pressure; Body Temperature; Decerebrate State; Dogs; Female; Fenfluramine; Guinea Pigs; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Oxotremorine; Quinolines; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Serotonin; Salivation; Serotonin; Serotonin Antagonists; Stereotyped Behavior | 1990 |